Investing Profile

Ben Auspitz

InvestorVC
Managing Partner, Breakout Fund at Curie.Bio
fprimecapital.comCambridge, Massachusetts
Photo of Ben Auspitz, Managing Partner at Curie.Bio
Your Intro Paths to Ben Auspitz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Ben is a member of
Quick Wins Network
577 CONNECTIONS
Quick Wins Network
577 CONNECTIONS
Quick Wins Network
577 CONNECTIONS
Quick Wins Network
577 CONNECTIONS
Les Fermes ExotiQC Network
435 CONNECTIONS

Find Ben Auspitz on

cb
Current Investing Position
Curie.Bio Managing Partner
Investment Range
$100K - $10.0M
Sweet Spot
$5.0M
Investments On Record
11

Ben Auspitz is on these Sector & Stage Rankings

Ben Auspitz's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
R1 Therapeutics
Series AMar 2026$78M
$78M
Co-investors: Andrew Sinclair (Abingworth), Chong Xu (F-Prime Capital (formerly Fidelity Biosciences))
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series CDec 2018$22M
Series BJun 2017$27M
$150M
Co-investors: Michael Powell (Omega Funds), Corey Goodman (venBio Partners), Daniel Coley (BrightEdge (American Cancer Society Impact Fund))
Modis Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Rishi Gupta (OrbiMed)
Compass Therapeutics
Series AJul 2018$49M
$160M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Stephen Squinto (J.P. Morgan Asset Management), Carl Gordon (OrbiMed Advisors), Julie Sunderland (Biomatics Capital Partners), George Godula (NutriSense), Peter Thiel (The Founders Fund), Phil Ferneau (Borealis Ventures)
Indalo Therapeutics
Series UnknownAug 2017$9M
$9M
Co-investors: Peter Barrett (Atlas Venture)
Avidity Biosciences
Series BJan 2017$16M
$120M
Co-investors: Roderick Wong (RTW Investments, LP)
Dimension Therapeutics
Series BApr 2015$65M
$65M
Co-investors: Mike Dybbs (Samsara BioCapital)
Ultragenyx Pharmaceutical
Series BDec 2012$75M
Series AJun 2011$45M
$120M
Co-investors: Marten Steen (HealthCap)

Ben Auspitz's Experience

Venture Partner Forge Life Science Partners2025 - Present
Managing Partner, Breakout Fund Curie.Bio2025 - Present
Consultant Les Fermes ExotiQCPresent
Consultant Quick WinsPresent
consultant Les Fermes ExotiQCPresent
consultant Quick WinsPresent
Chairman of the Board Les Fermes ExotiQCPresent
Chairman of the Board Quick WinsPresent
Chairman of the Board, Founder Les Fermes ExotiQCPresent
Chairman of the Board, Founder Quick WinsPresent
consultant Vertex PartnersPresent
Therapeutic Area Director, ZalicusPresent
Director UltragenyxPresent
Chairman of the Board Vertex PartnersPresent
Partner F-PrimePresent
Chairman of the Board, Founder Vertex PartnersPresent
Chairman of the Board, Founder Orchard Therapeutics - U.S.Present
Chairman of the Board IDRx2024 - 2025
Managing Partner, Founder Forge Life Science Partners2022 - 2025
Chief Executive Officer, Founder IDRx2021 - 2024
Partner F-Prime Capital2005 - 2021
Chairman of the Board Modis Therapeutics2018 - 2019
Chairman of the Board, Founder Orchard Therapeutics2015 - 2018
Chairman of the Board, Founder Dimension Therapeutics2013 - 2015
Director Ultragenyx Pharmaceutical Inc.2011 - 2014
Therapeutic Area Director, CombinatoRx2001 - 2005
consultant Braun Consulting1999 - 2000
Consultant Vertex Partners1995 - 1997

Investors who invest with Ben Auspitz

Sign in with Google →

Scouts & Angels Affiliated With Ben Auspitz

Sign in with Google →